National registry for chronic itch patients
Swiss Itch Registry (SWITCHR) - A Prospective Registry to Collect Data of Patients With Chronic Pruritus
University Hospital, Basel, Switzerland · NCT06120907
This study is creating a national registry for people in Switzerland with chronic itching to better understand their needs and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | University Hospital, Basel, Switzerland (other) |
| Locations | 1 site (Basel) |
| Trial ID | NCT06120907 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a national registry for patients suffering from chronic pruritus (itch) in Switzerland. Participants will undergo comprehensive assessments including patient-reported outcomes, physician evaluations, blood tests, and imaging techniques at specified intervals. The registry will facilitate a better understanding of patient needs, treatment outcomes, and safety issues related to chronic pruritus. Additionally, it will enable standardized comparisons of various pruritic conditions and enhance awareness among healthcare providers and authorities.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals aged 14 and older with a diagnosis of chronic pruritus and a minimum itch severity score.
Not a fit: Patients with conditions that prevent them from participating in the registry or those who refuse to complete necessary assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could significantly improve the management and treatment of chronic pruritus, leading to better patient outcomes.
How similar studies have performed: While this approach is novel in Switzerland, similar registries have shown success in other countries, indicating potential for impactful outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 14 years. * Written informed consent of the patient. * Diagnosis of CP irrespective of the International Forum for the Study of Itch (IFSI) group (I-III) and/or underlying cause (according to the judgment of the investigator). * A Numerical Rating Scale (NRS) score of min. ≥ 4 within the last 7 days. * Sufficient language skills (in the languages which the patient information and the consent form is available) to provide informed consent. Exclusion Criteria: * Any medical or psychological condition in the treating physician's opinion, which may prevent the patient in registry participation * Lack of informed consent for registry participation. * Refusal to complete Patient Reported Outcomes (PROs)
Where this trial is running
Basel
- Department of Dermatology, University Hospital Basel — Basel, Switzerland (RECRUITING)
Study contacts
- Principal investigator: Simon Mueller, PD Dr. med. — Department of Dermatology, University Hospital Basel
- Study coordinator: Simon Mueller, PD Dr. med.
- Email: simon.mueller@usb.ch
- Phone: +41 61 328 69 64
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pruritus, Itch, Chronic pruritus